Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase I Study of ICP-022 in Healthy Subjects
Phase 1
Completed
- Conditions
- Systemic Lupus ErythematosusRheumatoid Arthritis
- Interventions
- Drug: Placebos
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2019-08-01
- Lead Sponsor
- Innocare Pharma Australia Pty Ltd
- Target Recruit Count
- 64
- Registration Number
- NCT03189017
- Locations
- 🇦🇺
CMAX Clinical Research, Adelaide, South Australia, Australia
News
No news found